compounded semaglutide constipation for weight loss | Blog Constipation on Semaglutide: Relief Strategies
Description
Genetic predisposition testing is optional but may provide useful context
Research Summary Obesity Phase 2 Phase 2 Complete Phase 2 trial (n=338, non-diabetic obesity): 24-week dose escalation to 12 mg produced 17.5% weight reduction at 24 weeks, extrapolating to estimated 24% at 48 weeks
We are looking at not just your, uh, weight, but your body composition as well
This rebound is not failure
Sometimes I come across a story from Japan and think, Where do I even start with this? And that, dear reader, is where I find myself today
.png)
Betsy Grunch - Ladyspinedoc
